<DOC>
	<DOCNO>NCT00137410</DOCNO>
	<brief_summary>This phase III , multicentre , randomize , double blind , parallel-group , pilot study design compare long term ( 12 week ) versus short term ( 2 week ) treatment celecoxib 200 mg/die treatment prevention new flare patient osteoarthritis knee .</brief_summary>
	<brief_title>Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>diagnosis OA knee accord ACR Classification Criteria osteoarthritis ; patient flare concomitant inflammatory rheumatic condition may interfere assessment OA clinical radiological evidence chondrocalcinosis</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>